No Known Direct Interactions
Aspirin and Vascepa (icosapent ethyl) have no documented pharmacokinetic or pharmacodynamic interactions in major drug databases like Drugs.com, Lexicomp, or the Vascepa prescribing information. Vascepa, an EPA-only omega-3 fatty acid, primarily lowers triglycerides without affecting platelet aggregation or CYP enzymes that aspirin influences.[1][2]
Bleeding Risk Considerations
Both drugs mildly increase bleeding risk—aspirin via platelet inhibition, Vascepa via potential antithrombotic effects in high doses. Clinical trials like REDUCE-IT (18,000+ patients) allowed low-dose aspirin (≤162 mg/day) with Vascepa, showing no excess bleeding events compared to placebo. Higher aspirin doses (>325 mg) weren't studied, so monitor for bruising or prolonged bleeding.[2][3]
How They Work Together in Heart Patients
Vascepa is FDA-approved to reduce CV events in high-risk patients on statins, often with aspirin for secondary prevention. Real-world use combines them safely; guidelines (e.g., AHA/ACC) don't flag issues. Doses matter: Vascepa 4g/day with aspirin ≤81-162mg is standard.[3][4]
What Happens If You Take Them
No adjustments needed for most. Take aspirin with food if GI upset occurs; Vascepa with or without meals. Report unusual bleeding, black stools, or severe headache to a doctor. Liver function tests may be monitored long-term, but aspirin doesn't alter Vascepa's metabolism.[1][2]
Patient Reports and Edge Cases
User forums (e.g., Drugs.com reviews) note no interaction complaints; rare GI issues are drug-specific, not interactive. Avoid in active peptic ulcers or hemophilia. Consult a pharmacist for personalized advice, especially with anticoagulants like warfarin added.[1]
[1]: Drugs.com Drug Interaction Checker
[2]: Vascepa Prescribing Information (Amarin)
[3]: REDUCE-IT Trial (NEJM 2019)
[4]: AHA/ACC Cholesterol Guidelines (2018)